Home/Filings/4/0001493152-18-010233
4//SEC Filing

Drechsler Andrew T 4

Accession 0001493152-18-010233

CIK 0001695357other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 5:56 PM ET

Size

4.7 KB

Accession

0001493152-18-010233

Insider Transaction Report

Form 4
Period: 2018-07-19
Drechsler Andrew T
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2018-07-19$4.00/sh+6,250$25,0006,250 total
Footnotes (1)
  • [F1]The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 19, 2018.

Documents

1 file

Issuer

Provention Bio, Inc.

CIK 0001695357

Entity typeother

Related Parties

1
  • filerCIK 0001324734

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:56 PM ET
Size
4.7 KB